Gwendolyn Wu
ReporterGwendolyn is a reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn co-directs the AAJA Young Professionals Network, and teaches at the California Scholastic Press Association summer workshop. She has degrees in history and sociology from the University of California at Santa Barbara.
186 articles by Gwendolyn Wu
-
Canaan hires Pfizer executive, reels in $100M for biotech investing
April 17, 2024 -
Biotech landlord Alexandria on research clusters and the sector’s recovery
April 16, 2024 -
Biotech IPOs bounced back in first quarter, but backlog remains
April 12, 2024 -
Vertex to buy kidney disease drugmaker Alpine for $4.9B
April 10, 2024 -
Private biotech funding rises as venture firms deploy cash
April 8, 2024 -
Diagonal starts up with $128M to make better ‘activator’ antibody drugs
April 3, 2024 -
Ginkgo, in search of more cell therapy tools, buys another startup
April 2, 2024 -
Boundless Bio breaks IPO lull with $100M fundraise
March 28, 2024 -
SQZ, Portal founder Armon Sharei on starting over in biotech
March 26, 2024 -
Mirador debuts with $400M, picking up where immune drugmaker Prometheus left off
March 21, 2024 -
Clasp launches with $150M and a plan for precision cancer immunotherapies
March 20, 2024 -
German biotech Tubulis cashes in on ADC ‘momentum’ with €128M financing
March 14, 2024 -
Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
March 7, 2024 -
European VC Invivo readies its latest fund to back new biotechs
March 6, 2024 -
Sionna raises another $182M to challenge Vertex in cystic fibrosis
March 6, 2024 -
Biotech IPOs heated up to start 2024. Will the surge last?
March 5, 2024 -
Nocion, chasing GSK, pulls in $62M for chronic cough drug
March 4, 2024 -
FogPharma pulls in $145M to support cancer drug research
March 1, 2024 -
Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startup
Feb. 28, 2024 -
Frontier gets $80M, Galapagos’ backing to make a better KRAS drug
Feb. 22, 2024 -
Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies
Feb. 16, 2024 -
Versant-backed Firefly Bio wants to make the next generation of ADCs
Feb. 15, 2024 -
ADC startup ProfoundBio, led by Seagen veterans, raises $112M
Feb. 13, 2024 -
Two GV investors on biotech’s reset and building their next drug startups
Feb. 13, 2024 -
Gene editing biotech Metagenomi pulls off nearly $94M IPO
Feb. 8, 2024